SPDR S&P Biotech ETF Newsroom

$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today

Benzinga05:34

Capital Markets' Top 30 Global Ideas for the Fourth Quarter

Seeking Alpha02:41

CVS, Cigna PBMs Targeted as Lawmakers Criticize New "Anti-competitive" Move

Seeking Alpha02:26

AbbVie Withdraws Exviera From EU Market for Commercial Reasons

Seeking Alpha01:51

Incyte Analyst Ratings

BenzingaOct 1 18:05 · Ratings

Optimism Around Aquestive As It Moves Forward With Severe Allergy, Baldness Candidate

BenzingaOct 1 02:25

'Buy This; Sell That' Within Each Sector – Oppenheimer

Seeking AlphaSep 30 21:59

Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'

BenzingaSep 30 20:43

Reported Earlier, Alnylam's Vutrisiran Data Highlights Early Impact on Key Cardiac Biomarkers, Alnylam Eyes First-Line Therapy for ATTR Amyloidosis

BenzingaSep 30 15:05

Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says

Seeking AlphaSep 30 00:28

Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales

Seeking AlphaSep 30 00:12

Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations

Seeking AlphaSep 29 01:06

(ABBV) - Analyzing AbbVie's Short Interest

BenzingaSep 28 04:45

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential

BenzingaSep 28 03:06

Biotech IPOs Return as Sector Recovers After Funding Overhang

Seeking AlphaSep 28 02:49

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years

BenzingaSep 27 05:30

Healthcare Venture Investors Ante Up. Public Markets Remain Cool. -- Barrons.com

Barron'sSep 27 05:16

Exact Sciences, Quanterix Extend Slide After Medicare Rates

Seeking AlphaSep 27 03:35

Raymond James Reiterates Market Perform on Exact Sciences

BenzingaSep 27 00:55

Exact Sciences Analyst Ratings

BenzingaSep 27 00:53 · Ratings